Goldman Sachs just agreed to pay $2.25 billion for the firm behind a popular Bitcoin income ETF, and now shareholders face a question that cuts to the heart of why they bought in: does…
While investors chased chip stocks, one corner of the commodities market quietly staged a stunning run that has left even NVIDIA in the dust. The reason connects directly to how AI actually gets built.
Kevin Warsh walked into the Federal Reserve chairmanship and immediately faced a level of internal opposition not seen since Nixon was in the White House. What that number reveals about the next rate move…
JEPI and JEPQ both write calls for monthly income, but their 2026 payouts have drifted so far apart that retirees holding the wrong one are leaving serious cash on the table, and the reason…
Four major cryptocurrencies all posted double-digit gains over the past month, but strong rallies built on shaky foundations tend to collapse just as fast. The catalyst driving each one looks very different, and at…
Tesla's expanding robotaxi footprint is sending ripples through the rideshare market, and Uber shareholders are absorbing the hit even though Uber's own results gave them no reason to sell.
Bitcoin slipped Tuesday while the stocks built to mine it surged, breaking a correlation that defined the sector for years. Something structural is shifting beneath these miners, and it has nothing to do with…
Solana is about to flip a switch on a new transaction format while a sweeping consensus overhaul waits in the wings, but bigger and faster does not automatically mean more valuable for SOL holders.
Pivotal Research just slapped a price target on SpaceX that towers above where shares currently trade, and the space complex is rallying in response, but a looming supply risk could complicate the bull case…
RUM Group has soared past its social-media peers and moved into AI infrastructure, but a 33% monthly gain forces a real question about whether the best of this rally is already behind investors.
Lucid stock has cratered while rivals like Tesla and Rivian held their ground, and the company's latest financials reveal a tension between surging revenue and an alarming cash burn that puts every investor's next…
UMAC stock has exploded higher while its closest drone rivals have actually lost ground, putting investors at a crossroads that could define their returns for the rest of the year.
Arm's smartphone empire built one of tech's most recognizable businesses, but the company's next billion-dollar bet is pointing somewhere else entirely, and the valuation debate it has sparked puts bulls and bears in direct…
Wall Street just raised price targets on UiPath across the board after a strong earnings beat, yet not a single analyst upgraded the stock. Here is why four simultaneous target hikes are actually a…
Novartis just handed the entire Lp(a) drug class a failing grade, and Amgen is taking the worst of the punishment despite releasing promising trial results of its own on the very same morning.
